Psyence Biomedical (PBM) Institutional Ownership $5.38 -0.27 (-4.76%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$5.41 +0.03 (+0.61%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Psyence Biomedical (NASDAQ:PBM)CurrentInstitutional OwnershipPercentage77.44%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$38.89MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.27M Get PBM Insider Trade Alerts Want to know when executives and insiders are buying or selling Psyence Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PBM Institutional Buying and Selling by Quarter Psyence Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025AdvisorShares Investments LLC26,923$57K0.0%-97.8%0.408% 2/14/2025Harraden Circle Investments LLC182,323$385K0.3%N/A2.762% 2/11/2025Virtu Financial LLC12,692$27K0.0%N/A0.192% 2/10/2025Essential Planning LLC.73,278$163K0.0%N/A1.110% 8/8/2024AdvisorShares Investments LLC463,042$148K0.0%+70.7%5.269% 5/20/2024Virtu Financial LLC26,419$30K0.0%N/A0.301% (Data available from 1/1/2016 forward) PBM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PBM shares? During the previous two years, the following institutional investors and hedge funds held shares of Psyence Biomedical shares: Harraden Circle Investments LLC ($385K), Essential Planning LLC. ($163K), and AdvisorShares Investments LLC ($57K), Virtu Financial LLC ($27K).Learn more on Psyence Biomedical's institutional investors. What percentage of Psyence Biomedical's stock is owned by institutional investors? 77.44% of Psyence Biomedical's stock is owned by institutional investors. Learn more on PBM's institutional investor holdings. Which institutional investors have been buying Psyence Biomedical's stock? The following institutional investors have purchased Psyence Biomedical's stock in the last 24 months: AdvisorShares Investments LLC ($191.71K), Harraden Circle Investments LLC ($182.32K), Essential Planning LLC. ($73.28K), and Virtu Financial LLC ($39.11K). How much institutional buying is happening at Psyence Biomedical? Institutional investors have bought a total of 459,999 shares in the last 24 months. This purchase volume represents approximately $38.89M in transactions. Which of Psyence Biomedical's major shareholders have been selling company stock? The following institutional investors have sold Psyence Biomedical stock in the last 24 months: AdvisorShares Investments LLC ($1.21M). How much institutional selling is happening at Psyence Biomedical? Institutional investors have sold a total of 1,205,453 shares in the last 24 months. This volume of shares sold represents approximately $20.27M in transactions. Related Companies Minerva Neurosciences Major Shareholders Acurx Pharmaceuticals Major Shareholders Athira Pharma Major Shareholders Trinity Biotech Major Shareholders Bright Green Major Shareholders Phio Pharmaceuticals Major Shareholders Equillium Major Shareholders Brainstorm Cell Therapeutics Major Shareholders X4 Pharmaceuticals Major Shareholders BioXcel Therapeutics Major Shareholders This page (NASDAQ:PBM) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBM Stock Alerts